Dynamic profile of malondialdehyde in renal and hepatic ischemia reperfusion injury: an explorative study of internal historical samples

This explorative study analyzing historical rat and porcine samples reveals that malondialdehyde and GPX4 levels change within the first hours of reperfusion in renal and hepatic ischemia-reperfusion injury, suggesting early sampling is crucial for ferroptosis research and highlighting the potential protective role of dynamic preservation.

The Gist

The Big Picture: The "Rusty" Organ Problem

Imagine you have a car engine that has been sitting in a cold garage for a long time (this is like an organ waiting for a transplant). When you finally start the car and drive it, the engine gets hot and the oil starts to break down. If the oil gets too hot and breaks down, it turns into a sticky, toxic sludge that damages the engine parts.

In the human body, when an organ (like a kidney or liver) is cut off from blood flow (ischemia) and then blood rushes back in (reperfusion), a similar thing happens. The cells get stressed, iron builds up, and fats inside the cell membranes start to "rust." This process is called lipid peroxidation, and the toxic "rust" it creates is a chemical called Malondialdehyde (MDA).

Scientists believe this "rusting" process (called Ferroptosis) is a major reason why transplanted organs sometimes fail. This study tried to track exactly when and how much of this "rust" appears in different scenarios.

The Detective Work: Using Historical Clues

The researchers didn't run brand-new experiments from scratch. Instead, they acted like detectives looking at old case files. They dug up frozen blood and tissue samples from past experiments done on rats and pigs.

They were looking for two main clues:

1. MDA: The "rust" itself (the damage).
2. GPX4: The body's "rust remover" or antioxidant defense system.

What They Found (The Plot Twists)

1. The "Old Fridge" Problem (Storage Matters)

First, they hit a snag. They found that the age of the samples and how they were stored changed the results.

• The Analogy: Imagine taking a photo of a fresh apple. If you leave the photo in a hot, humid room for 10 years, the apple in the photo might look rotten, even if the real apple was fine.
• The Result: Samples stored at -20°C (a standard freezer) for 10 years showed high levels of "rust" (MDA) just because they sat there too long. The "rust" continued to form even after the animal was dead!
• The Lesson: To measure this accurately, you must freeze samples instantly at very low temperatures (-80°C) and analyze them quickly. Old samples are unreliable.

2. The Rat Experiments (Inside the Body)

They looked at rats where they temporarily stopped blood flow to the kidneys and liver.

• The Blood: Surprisingly, the "rust" levels in the rats' blood didn't change much between the injured rats and the healthy ones.
  • Why? MDA is like a hyper-active ninja. As soon as it's released into the blood, it attacks proteins and disappears. By the time the scientists tested the blood, the "rust" had already reacted with something else and was gone.
• The Tissue: Inside the actual organ tissue, they saw a slight increase in "rust" and a drop in the "rust remover" (GPX4) shortly after blood flow returned.
  • The Takeaway: The damage happens fast and locally inside the organ, but it's hard to catch in the bloodstream.

3. The Pig Experiments (Outside the Body)

This is where things got really interesting. They used pig organs in machines that mimic a body (perfusion machines).

• The Kidneys:
  • Kidneys that had been "warm" and ischemic (like a car engine overheating) produced a lot of "rust" when blood was pumped through them.
  • The Hero: When they used a special "cold, oxygenated" machine to preserve the kidneys first, the "rust" levels stayed low. It was like putting the engine in a cooling bath before starting it.
• The Livers:
  • Livers are tougher than kidneys regarding cold storage, but they are sensitive to long periods of warm perfusion.
  • When livers were perfused for a long time (24 hours), the "rust" levels spiked dramatically after 6 hours.
  • However, short-term perfusion seemed to calm things down, keeping the "rust" levels lower than expected.

The Conclusion: What Does This Mean for Us?

1. Timing is Everything: If you want to study organ damage, you have to look at the organ immediately after the injury. Waiting too long (like 24 hours) might mean you miss the peak of the "rusting" process.
2. Storage is Critical: You can't just freeze samples in a regular freezer and hope for the best. The "rust" keeps forming if the samples aren't handled perfectly.
3. Machine Perfusion is Promising: The study suggests that using advanced machines to keep organs cold and oxygenated before transplant might act as a shield, stopping the "rust" from forming and saving the organ.
4. One Clue Isn't Enough: The authors admit that looking at just "rust" (MDA) isn't enough to prove the specific type of cell death (Ferroptosis). They need more tools and markers to be 100% sure.

In short: This study is a "preliminary report" that tells us we need to be very careful with how we handle samples and when we measure them. It also gives us hope that new preservation machines might be able to stop the "rusting" process that kills transplanted organs.

Technical Summary

1. Problem Statement

Ischemia-Reperfusion Injury (IRI) is a primary cause of graft dysfunction and patient mortality in organ transplantation. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged as a key mechanism in IRI. However, the precise temporal dynamics of ferroptosis during transplantation—specifically when and how lipid peroxidation manifests in different organs and preservation conditions—remain unclear.

This study addresses the lack of data on the dynamic profile of Malondialdehyde (MDA), a byproduct of lipid peroxidation, and Glutathione Peroxidase 4 (GPX4), a key enzyme in redox defense, across various renal and hepatic IRI models. The authors aimed to utilize historical samples to map these dynamics, while also highlighting critical methodological pitfalls regarding sample storage and timing.

2. Methodology

This was an explorative study utilizing historical plasma, tissue, and perfusate samples from rat and porcine models of renal and hepatic IRI.

• Animal Models:
  • Rats (Sprague Dawley): Bilateral renal clamping (60 min warm ischemia) and partial liver clamping (70% liver, 60 min warm ischemia). Samples were collected at various reperfusion timepoints (6h, 24h, 48h).
  • Pigs (TOPIG_TN70): Ex vivo kidney and liver preservation models.
    • Kidneys: Compared groups with no ischemia, 22h Cold Ischemia (CI), and 60 min Warm Ischemia (WI). Models included normothermic whole blood reperfusion and hypothermic oxygenated machine perfusion (HOMP).
    • Livers: Compared groups with 2h CI vs. 2h CI + 60 min WI, subjected to prolonged (24h) or short-term (6h) normothermic machine perfusion (NMP) followed by whole blood reperfusion.
• Analytical Techniques:
  • MDA Quantification: Colorimetric assay using N-methyl-2-phenylindole, methanol, acetonitrile, and hydrochloric acid. Absorbance measured at 595 nm. Tissue values were normalized to protein concentration.
  • GPX4 Quantification: Western blotting to assess redox capacity.
• Data Handling: Statistical analysis performed using GraphPad Prism (ANOVA, Friedman test, etc.).

3. Key Contributions

• Validation of Sample Integrity: The study critically demonstrated that storage conditions and sample age significantly alter MDA measurements. Samples stored at -20°C or for ~10 years showed unreliable MDA levels due to ongoing lipid peroxidation post-sampling, whereas -80°C storage and rapid processing preserved integrity.
• Temporal Dynamics of Ferroptosis Markers: It provided a comparative timeline of MDA and GPX4 changes in vivo (rats) versus ex vivo (pigs), revealing that plasma MDA is often an unreliable marker due to rapid adduct formation, whereas tissue and perfusate MDA offer better insights.
• Organ-Specific Vulnerability: The study highlighted distinct differences in how kidneys and livers respond to ischemia and preservation methods regarding lipid peroxidation.

4. Key Results

A. In Vivo Rat Models

• Renal IRI:
  • Plasma: No significant difference in MDA between sham and IRI groups.
  • Tissue: A slight increasing trend in MDA was observed in male kidneys after 60 min WI, while female kidneys showed recovery by 48h.
  • GPX4: Significant reduction in GPX4 at 6h post-reperfusion (coinciding with peak injury), followed by recovery/exceeding sham levels by 48h, suggesting a compensatory mechanism.
• Hepatic IRI:
  • Gender Disparity: Significant increases in tissue MDA and decreases in GPX4 were observed in female rats at 24h post-reperfusion, but not in males.
  • Timing Limitation: Injury markers (AST/ALT) peaked at 6h and declined by 24h, suggesting that the 24h sampling point was too late to capture the peak ferroptotic activity in this specific model.

B. Ex Vivo Porcine Models

• Kidneys:
  • Warm Ischemia (WI): Kidneys exposed to 60 min WI showed a significant increase in perfusate MDA during normothermic reperfusion.
  • Cold Ischemia (CI): 22h CI kidneys did not show significant MDA increases.
  • Protective Effect: Hypothermic oxygenated perfusion (HOMP) attenuated MDA accumulation during subsequent reperfusion, keeping concentrations below 5 µM compared to ~10 µM in non-HOMP groups.
• Livers:
  • Prolonged NMP: MDA in liver tissue declined, but perfusate MDA increased significantly over 24h, with a major "burst" observed after 6 hours.
  • Short-term NMP: Livers subjected to short-term normothermic perfusion showed a milder MDA increase during subsequent reperfusion compared to prolonged perfusion, suggesting short-term NMP may dampen lipid peroxidation.
  • WI vs. CI: Unlike kidneys, livers exposed to short CI (2h) showed increasing MDA over time, reflecting the liver's different tolerance to cold ischemia compared to kidneys.

5. Significance and Limitations

• Significance:
  • Early Sampling is Critical: The study emphasizes that ferroptosis markers fluctuate rapidly; sampling must occur early (e.g., within the first 6 hours) to capture the peak of lipid peroxidation.
  • Biomarker Potential: MDA in perfusate (ex vivo) appears to be a more sensitive indicator of organ vulnerability and the efficacy of preservation strategies (like HOMP and NMP) than plasma MDA in vivo.
  • Methodological Warning: The findings serve as a cautionary tale for the field, proving that improper storage (e.g., -20°C) or delayed analysis can generate false positives for lipid peroxidation.
• Limitations:
  • Retrospective Nature: The study relied on historical samples not originally designed for ferroptosis analysis, leading to suboptimal timepoints and small sample sizes ($n=3$ in some porcine groups).
  • Marker Specificity: MDA alone is insufficient to confirm ferroptosis. The authors note that a comprehensive ferroptosis signature requires at least three additional markers (gene expression, mitochondrial changes, transferrin receptor mobilization) as per current consensus.
  • Storage Artifacts: The inability to use the oldest samples (10 years) highlights the fragility of MDA data.

Conclusion:
This explorative study confirms that MDA and GPX4 are dynamic markers affected within the first hours of reperfusion. It suggests that ischemic organs are highly vulnerable to lipid peroxidation, a process that can be mitigated by dynamic preservation techniques. However, the validity of these findings is strictly dependent on rigorous sample handling and early timepoint analysis, necessitating future prospective studies with optimized designs to fully characterize ferroptosis in transplantation.